High-performance liquid chromatographic determination of L-3,4-dihydroxy-phenylalanine (L-DOPA) and its metabolites in the urine of patients with Parkinson's disease, control patients and normal subjects after oral administration of L-DOPA

Chem Pharm Bull (Tokyo). 1981 Mar;29(3):789-95. doi: 10.1248/cpb.29.789.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Chromatography, High Pressure Liquid / methods
  • Female
  • Humans
  • Levodopa / urine*
  • Male
  • Middle Aged
  • Parkinson Disease / urine*

Substances

  • Levodopa